Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Gilead's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
65.82 -1.26    -1.88%
10:19:46 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 1,563,302
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 65.76 - 67.90
Type:  Equity
Market:  United States
Gilead 65.82 -1.26 -1.88%

GILD Financial Summary

 
A brief financial summary of Gilead Sciences Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Gilead Sciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 7,051 million compared to USD 7,042 million a year ago. Net income was USD 2,180 million compared to USD 1,789 million a year ago. Basic earnings per share from continuing operations was USD 1.75 compared to USD 1.43 a year ago. Diluted earnings per share from continuing operations was USD 1.73 compared to USD 1.42 a year ago.For the nine months, revenue was USD 20,002 million compared to USD 19,892 million a year ago. Net income was USD 4,236 million compared to USD 2,952 million a year ago. Basic earnings per share from continuing operations was USD 3.39 compared to USD 2.35 a year ago. Diluted earnings per share from continuing operations was USD 3.37 compared to USD 2.34 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

GILD Income Statement

Gross margin TTM 77.8%
Operating margin TTM 36.15%
Net Profit margin TTM 20.89%
Return on Investment TTM 16.02%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 7114 7050 6599 6352
Gross Profit 5503 5485 5157 4951
Operating Income 3003 2715 1909 2182
Net Income 1429 2180 1045 1010

GILD Balance Sheet

Quick Ratio MRQ 1.15
Current Ratio MRQ 1.43
LT Debt to Equity MRQ 101.56%
Total Debt to Equity MRQ 112.37%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 62125 62373 62337 61876
Total Liabilities 39376 40131 41243 40937
Total Equity 22749 22242 21094 20939

GILD Cash Flow Statement

Cash Flow/Share TTM 6.43
Revenue/Share TTM 21.76
Operating Cash Flow  19.23%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 2169 1755 2338 1744
Cash From Investing Activities -727 -229 -483 -826
Cash From Financing Activities -1099 -1519 -1101 -1406
Net Change in Cash 380 1 768 -476
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Neelay Patel
Neelay Patel Oct 24, 2020 11:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it a buy right now or wait for any positive news?
Daniel Lou
Daniel Lou Oct 24, 2020 11:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looks like it was a buy right now
Caleb Mitchell
Caleb Mitchell Oct 06, 2020 11:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
do you think Trump showing fast signs of recovery and also using Gilead medicine will cause the stock to go up?
Dark Roast
Dark Roast Jul 13, 2020 8:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
More fake news about Gilead to boost stocks lol
Cathy Martin
Cathy Martin Jul 13, 2020 8:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Health canada hs approved remdesivir
Jesse Clarke
Jesse Clarke Apr 30, 2020 12:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
if theres a single complication its gonna crash like a plane. high risk high reward
Adam Nicholson
Adam Nicholson Apr 30, 2020 12:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Exactly. Probably won't go down past 65 though where is was before all this.
Hiren Baraiya
Hiren Baraiya Apr 30, 2020 12:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They just waiting for the results , if any step in positive direction then we will see a jump bigger than MRNA
Bradley Cherniwchan
Bradley Cherniwchan Apr 30, 2020 10:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I hoping for a new record high
Reoben Cabrera II
Reoben Cabrera II Apr 30, 2020 10:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how much gain do you guys think it will do?
Bradley Cherniwchan
Bradley Cherniwchan Apr 30, 2020 10:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This one is gonna rocket!!
richard Kim
richard Kim Apr 29, 2020 15:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA coming
just setup
just setup Apr 29, 2020 11:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sponsored by Republicans. lol
Dark Roast
Dark Roast Apr 29, 2020 10:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
More fake news just wait😷
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email